药物对比
Erenumab vs Lasmiditan
Erenumab（Aimovig）是预防性CGRP单克隆抗体，Lasmiditan（Reyvow）是用于偏头痛急性治疗的5-HT1F激动剂。比较作用机制、疗效和适用情况。
此页面暂无可用的对比维度。
临床背景
Patients looking to switch from one migraine medication to another or comparing preventive options often search for Erenumab vs Lasmiditan.
结论
Both Erenumab and Lasmiditan are valuable migraine treatments but are used for different purposes.
全部药物对比